In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of apoA-I mutants in apoA-I-deficient mice

被引:20
作者
Reardon, CA
Kan, HY
Cabana, V
Blachowicz, L
Lukens, JR
Wu, QZ
Liadaki, K
Getz, GS
Zannis, VI
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Mol Genet Sect, Boston, MA 02118 USA
关键词
D O I
10.1021/bi011451e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used adenovirus-mediated gene transfer in apoA-I-deficient (A-I-/-) mice to probe the in vivo assembly and metabolism of HDL using apoA-I variants, focusing primarily on the role of the C-terminal 32 amino acids (helices 9-10). Lipid, lipoprotein, and apoA-I analyses showed that plasma levels of apoA-I and HDL of the mutants were 40-88% lower than that of wild type (WT) human apoA-I despite comparable levels of expression in the liver. WT apoA-I and mutant 1 (P165A, E172A) formed spherical particles with the size and density of HDL2 and HDL3. Mutant 2 (E234A, E235A, K238A, K239A) generated spherical particles with density between HDL2 and HDL3. Mutant 3 (L211V, L214V, L218V, L219V) and mutant 4 (L222K, F225K, F229K), which have substitutions of hydrophobic residues in the C-terminus, generated discoidal HDL particles indicating a defect in their conversion to mature spherical HDL. Significant amounts of mutant 4 and mutant 5 (truncated at residue 219) were found in the lipid poor fractions after ultracentrifugation of the plasma (18 and 35%, respectively, of total apoA-I). These findings suggest that hydrophobic residues in and/or between helices 9 and 10 are important for the maturation of HDL in vivo.
引用
收藏
页码:13670 / 13680
页数:11
相关论文
共 42 条
[21]   APOLIPOPROTEIN-E DEFICIENCY IN MICE - GENE REPLACEMENT AND PREVENTION OF ATHEROSCLEROSIS USING ADENOVIRUS VECTORS [J].
KASHYAP, VS ;
SANTAMARINAFOJO, S ;
BROWN, DR ;
PARROTT, CL ;
APPLEBAUMBOWDEN, D ;
MEYN, S ;
TALLEY, G ;
PAIGEN, B ;
MAEDA, N ;
BREWER, HB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1612-1620
[22]   The structure of human lipoprotein A-I - Evidence for the "belt" model" [J].
Koppaka, V ;
Silvestro, L ;
Engler, JA ;
Brouillette, CG ;
Axelsen, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :14541-14544
[23]   The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein [J].
Kozyraki, R ;
Fyfe, J ;
Kristiansen, M ;
Gerdes, C ;
Jacobsen, C ;
Cui, SY ;
Christensen, EI ;
Aminoff, M ;
de la Chapelle, A ;
Krahe, R ;
Verroust, PJ ;
Moestrup, SK .
NATURE MEDICINE, 1999, 5 (06) :656-661
[24]   The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein [J].
Laccotripe, M ;
Makrides, SC ;
Jonas, A ;
Zannis, VI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) :17511-17522
[25]   High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1 [J].
McNeish, J ;
Aiello, RJ ;
Guyot, D ;
Turi, T ;
Gabel, C ;
Aldinger, C ;
Hoppe, KL ;
Roach, ML ;
Royer, LJ ;
de Wet, J ;
Broccardo, C ;
Chimini, G ;
Francone, OL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4245-4250
[26]  
MINNICH A, 1992, J BIOL CHEM, V267, P16553
[27]   Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic α-helixes [J].
Mishra, VK ;
Palgunachari, MN ;
Datta, G ;
Phillips, MC ;
Lund-Katz, S ;
Adeyeye, SO ;
Segrest, JP ;
Anantharamaiah, GM .
BIOCHEMISTRY, 1998, 37 (28) :10313-10324
[28]  
MORRISON J, 1991, J BIOL CHEM, V266, P18780
[29]   CONFORMATIONAL-ANALYSIS OF APOLIPOPROTEIN A-I AND E-3 BASED ON PRIMARY SEQUENCE AND CIRCULAR-DICHROISM [J].
NOLTE, RT ;
ATKINSON, D .
BIOPHYSICAL JOURNAL, 1992, 63 (05) :1221-1239
[30]  
OMEARA NM, 1994, J LIPID RES, V35, P2178